Table 3.
Information related to major child health program coverage that may have contributed to reductions in all-cause child mortality between the DHS-2001/2 and the DHS-2007
| Indicator | 2001/2 DHS | 2007 DHS | Percent change (%) |
|---|---|---|---|
| Mortality rates* | |||
| Infant mortality (0–11 months) | 95 | 70 | ↓ 26 |
| Neonatal mortality (< 1 month) | 37 | 34 | ↓ 8 |
| Post-neonatal mortality (1–11 months) | 58 | 36 | ↓ 38 |
| Child mortality (1–4 yrs) | 81 | 52 | ↓ 36 |
| Under 5 mortality (0–5 years) | 168 | 119 | ↓ 29 |
| Coverage of interventions among children | |||
| Percent stunted (children under 5 years) | 46.8 | 45.4 | ↓ 3 |
| Percent wasted (children under 5 years) | 5.0 | 5.2 | ↑ 4 |
| Percent underweight (children under 5 years) | 28.1 | 14.6 | ↓ 48 |
| Percent of youngest children under 6 months who are exclusively breastfed | 40.1 | 60.9 | ↑ 52 |
| Percent of children age 12–15 months still breastfeeding | 96.8 | 93.8 | ↓ 4 |
| Percent of children age 20–23 months still breastfeeding | 55.5 | 41.7 | ↓ 25 |
| Percent of children age 12–23 months with BCG vaccination | 94.0 | 92.3 | ↓ 2 |
| Percent of children age 12–23 months with at least 3 polio vaccinations | 80.2 | 77.0 | ↓ 4 |
| Percent of children age 12–23 months with measles vaccination | 84.4 | 84.9 | ↑ 1 |
| Percent of children age 0–59 months with diarrhea in the 2 weeks preceding the survey who received oral rehydration salts (ORS) or recommended home fluids | 66.9 | 66.8 | ↔ 0 |
| Percent of children age 0–59 months with acute respiratory infection (ARI) in the 2 weeks preceding the survey who were taken to a health provider | 69.1 | 68.2 | ↓ 2 |
| Percentage of households with at least one ITN | 13.6 | 53.3 | ↑ 292 |
| Percentage of children 0–59 months who slept under an ITN on the previous night | 9.8 | 28.5 | ↑ 192 |
| Percentage of pregnant women 15–49 who slept under an ITN on the previous night | 7.9 | 32.7 | ↑ 314 |
| Percent of children age 0–59 months with a fever in the 2 weeks preceding the survey who took an anti-malarial drug | 51.9 | 38.4 | ↓ 27 |
| Percent of children age 0–59 months with a fever in the 2 weeks preceding the survey who took an anti-malarial drug the same day/next day after developing fever | 36.8 | 20.5 | ↓ 44 |
*
Mortality calculated as deaths per 1,000 live births except for child mortality, which is calculated as deaths per 1,000 children surviving to 12 months of age.